Monopar Therapeutics - Common Stock, $0.001 par value (MNPR)

CUSIP: 61023L207

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class
Equity / Common Stock, $0.001 par value
Total 13F shares
6,222,139
Total 13F value
$576,133,337
Holder snapshot 6 signals
Share change
-8,061
SEC-reported price per share
$92.59
Number of holders
95
Value change
+$12,667,679
Number of buys
61
Number of sells
36
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
6,667,745

Security key

61023L207

Report period

Q2 2026

Institutions

95

Top holders

10

MNPR full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 Monopar Therapeutics SEC filings Monopar Therapeutics company facts Monopar Therapeutics 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MNPR - Monopar Therapeutics - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
Janus Henderson Group Ltd.
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G 13F 3/4/5 Lead comparable stake: 20% 13D/G row: Janus Henderson Group Ltd. Showing 1-6 of 15 holder rows.

Quick read

Janus Henderson Group Ltd. leads the comparable SEC ownership view at 20%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Janus Henderson Group Ltd.'s linked filing trail.
Comparable ownership Top 5
Janus Henderson Group Ltd. 20%
RA CAPITAL MANAGEMENT, L.P. 9.9%
ASTRAZENECA PLC 7.8%
Adage Capital Management, L.P. 4.8%
Saturn V Capital Management LP 4.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Janus Henderson Group Ltd.
13D/G 13F
JANUS HENDERSON GROUP PLC · Company
13D/G 13F
20%
$105,138,701
1,287,368 shares
 +$9,391,992 30 Sep 2025
RA CAPITAL MANAGEMENT, L.P.
13D/G 13F
Company
13D/G 13F
9.9%
$43,402,756
667,632 shares
 -$4,890,637 31 Dec 2025
ASTRAZENECA PLC
13D/G
13D/G
7.8%
$34,126,392
522,667 shares
 $0 31 Dec 2025
Adage Capital Management, L.P.
13D/G
13D/G
4.8%
$31,485,818
324,195 shares
 -$9,712,000 30 Jun 2026
Saturn V Capital Management LP
13D/G 13F
Company
13D/G 13F
4.7%
$30,435,854
313,384 shares
 -$3,131,343 30 Jun 2026
Hendricks Diane
3/4/5
10%+ Owner
3/4/5
8.5%
$50,213,802
567,580 shares
 — 16 Dec 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
95
Shares
6,222,139
Rows available
95
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
82
Q2 2026 holders
95
Holder diff
13
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .